160 related articles for article (PubMed ID: 23934363)
1. Therapeutic human cells: manufacture for cell therapy/regenerative medicine.
van den Bos C; Keefe R; Schirmaier C; McCaman M
Adv Biochem Eng Biotechnol; 2014; 138():61-97. PubMed ID: 23934363
[TBL] [Abstract][Full Text] [Related]
2. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
Abbasalizadeh S; Baharvand H
Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic cell therapy manufacturing: process development technologies and facility design options.
Abbasalizadeh S; Pakzad M; Cabral JMS; Baharvand H
Expert Opin Biol Ther; 2017 Oct; 17(10):1201-1219. PubMed ID: 28699788
[TBL] [Abstract][Full Text] [Related]
4. Stem cells: are we ready for therapy?
Schroeder IS
Methods Mol Biol; 2014; 1213():3-21. PubMed ID: 25173369
[TBL] [Abstract][Full Text] [Related]
5. Stem Cells Derived from Amniotic Fluid: A Potential Pluripotent-Like Cell Source for Cellular Therapy?
Ramasamy TS; Velaithan V; Yeow Y; Sarkar FH
Curr Stem Cell Res Ther; 2018; 13(4):252-264. PubMed ID: 29336267
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells.
Rami F; Beni SN; Kahnamooi MM; Rahimmanesh I; Salehi AR; Salehi R
Cell Reprogram; 2017 Apr; 19(2):65-74. PubMed ID: 28266864
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells and their implication for regenerative medicine.
Csobonyeiova M; Polak S; Koller J; Danisovic L
Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine.
Laurent A; Abdel-Sayed P; Hirt-Burri N; Scaletta C; Michetti M; de Buys Roessingh A; Raffoul W; Applegate LA
Cells; 2021 Sep; 10(10):. PubMed ID: 34685505
[TBL] [Abstract][Full Text] [Related]
9. An Innovative, Comprehensive Mapping and Multiscale Analysis of Registered Trials for Stem Cell-Based Regenerative Medicine.
Monsarrat P; Vergnes JN; Planat-Bénard V; Ravaud P; Kémoun P; Sensebé L; Casteilla L
Stem Cells Transl Med; 2016 Jun; 5(6):826-35. PubMed ID: 27075765
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord blood: a trustworthy source of multipotent stem cells for regenerative medicine.
Jaing TH
Cell Transplant; 2014; 23(4-5):493-6. PubMed ID: 24816446
[TBL] [Abstract][Full Text] [Related]
11. Regenerative capacity of autologous stem cell transplantation in elderly: a report of biomedical outcomes.
Gonzalez-Garza MT; Cruz-Vega DE
Regen Med; 2017 Mar; 12(2):169-178. PubMed ID: 28244829
[TBL] [Abstract][Full Text] [Related]
12. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review.
Vonk LA; de Windt TS; Slaper-Cortenbach IC; Saris DB
Stem Cell Res Ther; 2015 May; 6(1):94. PubMed ID: 25976213
[TBL] [Abstract][Full Text] [Related]
13. The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products.
Lowdell MW; Thomas A
Br J Haematol; 2017 Jan; 176(1):9-15. PubMed ID: 27748517
[TBL] [Abstract][Full Text] [Related]
14. The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products.
Rafiq QA; Ortega I; Jenkins SI; Wilson SL; Patel AK; Barnes AL; Adams CF; Delcassian D; Smith D
Regen Med; 2015 Nov; 10(8):989-1003. PubMed ID: 26628407
[TBL] [Abstract][Full Text] [Related]
15. Emerging stem cell based strategies for treatment of childhood diseases.
Sniecinski I; Seghatchian J
Transfus Apher Sci; 2018 Jun; 57(3):311-315. PubMed ID: 29793820
[TBL] [Abstract][Full Text] [Related]
16. Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction.
Reich H; Tseliou E; de Couto G; Angert D; Valle J; Kubota Y; Luthringer D; Mirocha J; Sun B; Smith RR; Marbán L; Marbán E
J Heart Lung Transplant; 2016 Nov; 35(11):1348-1357. PubMed ID: 27342903
[TBL] [Abstract][Full Text] [Related]
17. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
Osakada F
Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
[TBL] [Abstract][Full Text] [Related]
18. Stem cells: promises versus limitations.
Choumerianou DM; Dimitriou H; Kalmanti M
Tissue Eng Part B Rev; 2008 Mar; 14(1):53-60. PubMed ID: 18454634
[TBL] [Abstract][Full Text] [Related]
19. Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products.
Hourd P; Chandra A; Alvey D; Ginty P; McCall M; Ratcliffe E; Rayment E; Williams DJ
Regen Med; 2014; 9(6):799-815. PubMed ID: 25431916
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic and autologous mode of stem cell transplantation in regenerative medicine: which way to go?
Mamidi MK; Dutta S; Bhonde R; Das AK; Pal R
Med Hypotheses; 2014 Dec; 83(6):787-91. PubMed ID: 25456787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
